Monetization around convertible debt financing is expected — two chief commercial officers and a director sold small positions for cash. The cluster is too small to signal a bearish view. Watch for any subsequent 10b5-1 plan filings and the next quarterly report (due early August) to gauge operating performance. No trade action warranted from this filing alone.
Price Chart
Executive Summary
Three Adaptive Biotechnologies insiders (a director and both chief commercial officers) sold a total of ~$1.39M in open-market shares immediately after the company issued $345M in convertible notes and repurchased $156.9M of a revenue interest agreement. The insider cluster is entirely selling and the dollar value is ~0.04% of the $3.4B market cap, well below the 0.1% trivial threshold, making this a routine liquidity event — likely tied to post-convertible-deal portfolio rebalancing and option exercise hedging. The cross-filing amplifier verdicts (cluster-offering-context + cluster-insider-trades) are statistically significant but cannot override the trivial economic magnitude; a 4bp cluster has no material directional signal.
Key Financial Metrics
Key Facts
- Three insiders sold $1.39M total in open-market sales (director Griffin $1.05M, CCO Benzeno $232K, CCO Bobulsky $103K) on June 25-26, 2026
- Sales occurred 3-4 days after $345M convertible note issuance — likely post-deal liquidity/hedging
- Total cluster value of $1.39M is ~0.04% of $3.4B market cap — trivial by proportionality standards
- Two insiders also exercised derivatives concurrently at $12.14-$7.80 strike prices with tax-withholding and open-market sales
- Previous 30 days showed 4 insider sells totaling $4.7M — the current cluster is a continuation of routine selling patterns
Financial Impact
Insider selling totals $1.39M, or ~0.04% of market cap — economically insignificant and within normal portfolio rebalancing/hedging activity
Risk Factors
- Insider selling could accelerate if stock continues to rise post-convertible deal — monitor daily Form 4 filings
- The $345M convertible adds leverage; any operating miss could pressure equity
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ADPT-1782861934865 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 19d ago | 144 | $26.28 | awaiting T+20 | — | $26.27 (−0.04%) |
Oct 5, 2026 20d ago | Insider Cluster | $26.90 | awaiting T+20 | — | $26.27 (−2.34%) |
Sep 25, 2026 4w ago | Press Release | $29.43 $25.51 | ▼ −13.32% | ▼ −11.84% | $26.27 (−10.74%) |
Sep 18, 2026 5w ago | Insider Cluster | $27.86 $23.95 | ▲ +14.03% | ▲ +13.13% | $26.27 (+5.71%) |
Aug 20, 2026 9w ago | Insider Cluster | $25.99 $27.86 | ▲ +7.20% | ▲ +7.72% | $26.27 (+1.08%) |
Aug 19, 2026 9w ago | Insider Cluster | $25.44 $28.55 | ▼ −12.22% | ▼ −12.22% | $26.27 (−3.26%) |
Aug 18, 2026 9w ago | 144 | $25.49 $26.68 | ▲ +4.67% | ▲ +6.19% | $26.27 (+3.06%) |
Aug 17, 2026 9w ago | 144 | $24.56 $27.67 | ▼ −12.66% | ▼ −13.97% | $26.27 (−6.96%) |
Jul 29, 2026 12w ago | Institutional Cluster | $24.18 $26.44 | ▼ −9.35% | ▼ −5.38% | $26.27 (−8.64%) |
Jul 23, 2026 13w ago | Insider Cluster | $22.27 $25.99 | ▲ +16.70% | ▲ +13.08% | $26.27 (+17.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers